According to the relevant provisions of the “Administrative Regulations on Veterinary Drugs” and “Administrative Regulations on Feeds and Feed Additives”, in accordance with development of the “National Action Plan to Contain Bacterial Drug Resistance (2016-2020)” and the “National Action Plan to Contain Drug-resistant Bacteria from Animal Sources (2017-2020)”, in order to maintain the safety of animal-derived food and public health in our country, our ministry decided to stop production, import, operation, use of some medical feed additives, and make adjustments to relevant management policies. The relevant matters are announced as follows.
1. With effect from January 1, 2020, all varieties of growth-promoting medical feed additives except traditional Chinese medicines will be withdrawn, veterinary drug production companies will stop production, importing agents will stop importing corresponding feed additives. Meanwhile the approval number of corresponding product and registration certificate of importing product will be cancelled. The corresponding products that have been produced or imported before can be circulated until June 30, 2020.
2. From July 1, 2020, feed production companies shall stop producing commercial feed which contains growth-promoting medical feed additives (except traditional Chinese medicines). The commercial feed that has been produced before can be used until December 31, 2020.
3. Before January 1, 2020, our ministry will organize the revision to the quality standards for varieties that have both growth-promoting and therapeutical purposes, repeal the usage of growth-promoting purposes, and just keep the therapeutical purposes.
4. Change the management method of anticoccidial and traditional Chinese medicine feed additives. The approval number of “Veterinary Drug Additives” will be no longer issued, which will be replaced with “Veterinary Drug”. Feed additives with this approved number can be used in both commercial feed and on-site farm. Before January 1, 2020, our ministry will organize the revision to the quality standards and labeling instructions for anticoccidial and traditional Chinese medicine feed additives.
5. Before July 1, 2020, our ministry will complete the change of the approval number of the corresponding medical feed additives from “Veterinary Drug Additives” to “Veterinary Drug”.
6. From July 1, 2020, the former Announcement No. 168 and No. 220 shall be repealed.
Ministry of Agriculture and Rural Affairs
Table 1. Twelve growth promoter medical feed additives (AGPs)
|No.||Feed additive name||Application||Target animal|
|1||Narasin Premix||Growth promoter,
|2||Oxytetracycline Calcium Premix||Growth promoter,Prevention||Pig, Chicken,Duck|
|3||Avilamycin Premix||Growth promoter,
|4||Enramycin Premix||Growth promoter,
|5||Kitasamycin Premix||Growth promoter||Pig,Chicken|
|6||Bacitracin Methylene Disalicylate Premix||Growth promoter||Pig,Broiler,meat-duck|
|7||Nosiheptide Premix||Growth promoter||Pig,Chicken|
|8||Bacitracin Zinc Premix||Growth promoter||Cattle,Pig,Poultry|
|9||Chlortetracycline Premix||Growth promoter||Pig,Chicken|
|10||Flavomycin Premix||Growth promoter||Pig,Chicken,Beef|
|11||Virginiamycin Premix||Growth promoter||Pig,Chicken|
|12||Quinocetone Premix||Growth promoter||Pig|
Note: 1.Medical feed additives with both promoting growth and prevention application (3 kinds):
Oxytetracycline Calcium Premix, Avilamycin Premix, Enramycin Premix.
2.Medical feed additives with both promoting growth and anticoccidial application (1 kind): Narasin Premix
It should be particularly noted, as growth promoter ,the applications of 12 kinds medical feed additives in Tabel 1 will be prohibited, however, as prevention application, Oxytetracycline Calcium Premix, Avilamycin Premix, Enramycin Premix can be retained. However, in this announcement, it is not clearly state under which classification these 3 kinds be managed.
In addition to the growth-promoting function, Narasin Premix can be used as anticoccidials. According to the provisions of the Announcement No. 194, the application as anticoccidial purpose will be retained and it will be managed under “Veterinary Drugs” after July 1, 2020.